Semple, Erin A; Harberson, Mitchell T; Xu, Baijie; Rashleigh, Rebecca; Cartwright, Tori L; Braun, Jessica J; Custer, Amy C; Liu, Chen; Hill, Jennifer W
description
Female sexual dysfunction affects approximately 40% of women in the United States, yet few therapeutic options exist for these patients. The melanocortin system is a new treatment target for hypoactive sexual desire disorder (HSDD), but the neuronal pathways involved are unclear.
